CrushSCI.com
315平均天数
279中位天数
164最短天数
641最长天数
2022025发文量

Paper Review Records

全部论文审稿周期

16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

220 天

Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations

作者
Xiuning Le; Jie Wang; Yan Yu; Yanqiu Zhao; David Planchard; Bo Gao; Alexander Spira; Jingling Liu; Xingya Li; Shirish Gadgeel; Natasha Leighl; Junqiang Zhang; Hidetoshi Hayashi; Makoto Nishio; Julien Mazieres; Adrianus Johannes de Langen; Maurice Pérol; Kiyotaka Yoh; Martin D. Forster; Yasushi Goto; Maria de Miguel Luken; Fernando Fabio Franco Perez; Quincy Chu; Sagun Parakh; Monique B. Nilsson; Yong Jiang; Tianhua Hu; Cunlin Wang; Nichole Baio; Luna Musib; Zineb Mounir; Marcin Kowanetz; Shirley Wang; Steven Yea; Jerry Hsu; Stuart Lutzker; John V. Heymach; Oscar Juan-Vidal; Jonathan W. Riess展开收起
作者单位
University of Texas MD Anderson Cancer Center, Houston, TX, USA; Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China; Harbin Medical University Cancer Hospital, Harbin, China; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China; Institut Gustave Roussy, Department of Medical Oncology, Villejuif, France; Blacktown Cancer and Haematology Centre, Blacktown, NSW, Australia; Virginia Cancer Specialists Research Institute and Next Oncology, Fairfax, VA, USA; Jilin Cancer Hospital, Changchun, China; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Henry Ford Cancer Institute, Detroit, MI, USA; Princess Margaret Cancer Centre, Toronto, ON, Canada; Anhui Provincial Hospital, Hefei, China; Kindai University Hospital, Osaka, Japan; Cancer Institute Hospital of JFCR, Tokyo, Japan; Toulouse University Hospital, Toulouse, France; Netherlands Cancer Institute, Amsterdam, the Netherlands; Léon Bérard Center, Lyon, France; National Cancer Center Hospital East, Kashiwa, Japan; UCL Cancer Institute/University College London Hospital NHS Trust, London, UK; National Cancer Center Hospital, Tokyo, Japan; START-Rioja, CIBIR, Hospital Universitario San Pedro, Logroño, Spain; MD Anderson Cancer Center, Madrid, Spain; Cross Cancer Institute, Edmonton, AB, Canada; Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, Heidelberg, Melbourne, VIC, Australia; Allist Pharmaceuticals, Shanghai, China; ArriVent BioPharma, Inc., Newtown Square, PA, USA; La Fe University and Polytechnic Hospital, Valencia, Spain; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA展开收起
PDF源文件 DOI 网页
164 天

Chemotherapy enhances cancer vaccine efficacy and expands stem-like TCF1+CD8+ T cells

作者
Laurine Noblecourt; Amanda Wicki; Ashwin Jainarayanan; Vinnycius Pereira-Almeida; James McAuliffe; Emily Steffke; Silvia Panetti; Hannah Fuchs; Ramiro A. Ramirez-Valdez; Vineethkrishna Chandrasekar; Yanshu Cai; Sanne Boekestijn; Adrian V.S. Hill; Audrey Gerard; Marij J.P. Welters; Sjoerd H. Van der Burg; Isabela Pedroza-Pacheco; Benoit J. Van den Eynde; Carol Sze Ki Leung展开收起
作者单位
Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Albinusdreef, 2, 2333 ZA Leiden, the Netherlands; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Ludwig Institute for Cancer Research, de Duve Institute, UCLouvain, Brussels, Belgium; WEL Research Institute, Brussels, Belgium展开收起
PDF源文件 DOI 网页
491 天

A transient MXD4-dependent proliferative pause enables survival of brain micrometastases

作者
Pedro García-Gómez; Diana Retana; Carolina Hernández-Oliver; Oliva Sánchez; Neibla Priego; Laura Álvaro-Espinosa; Lluís Cordón-Barris; Ana de Pablos-Aragoneses; Juan Vázquez-Cantó; Andrea Rojas; Catalina Vela-Gual; Beatriz Ocaña-Tienda; Samuel Morabito; Anna Pascual-Reguant; Pablo Sanz-Martínez; Manan Krishnamurthy; Ajit Kumar Sharma; Luise Rupp; Antonia Stammberger; Sara Carpintero; Rachel Scott; Carlos Garrido; María Gómez; María Isabel García; Kevin Troulé; Verona Villar-Cerviño; Guillermo Garaulet; Antonio Rodríguez; Srinivas Malladi; Nathan Beckouche; Eduardo Caleiras; Sandra Rodriguez-Perales; Raúl Torres-Ruiz; Fátima Al-Shahrour; Miguel Lafarga; Monica Sivakumar; David A. Moore; Cristina Naceur-Lombardelli; Charles Swanton; Holger Heyn; Helen M. Byrne; Víctor M. Pérez-García; Anish Thomas; Marc Schmitz; Mariam Jamal-Hanjani; Manuel Valiente展开收起
作者单位
Brain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Mathematical Oncology Laboratory (MOLAB), University of Castilla-La Mancha, Ciudad Real, Spain; Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain; Center for Cancer Research, NCI, Bethesda, MD, USA; Medical Scientist Training Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany; Molecular Cytogenetics and Cancer Genome Engineering Lab, Cancer Genomics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK; Histopathology Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas & Universidad Miguel Hernández, Sant Joan d’Alacant, Spain; Molecular Imaging Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Department of Molecular Biology, Universidad Autonoma de Madrid, Madrid, Spain; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA; AtmosR, Fuveau, France; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnologicas (CIEMAT), Madrid, Spain; Advanced Therapies Unit, Instituto de Investigacion Sanitaria Fundacion Jiménez Díaz, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Santander, Spain; Departamento de Anatomía y Biología Celular, Universidad de Cantabria, Santander, Spain; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Cellular Pathology, University College London Hospitals, London, UK; Department of Oncology, University College London Hospitals, London, UK; Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK; Mathematical Institute, University of Oxford, Oxford, UK; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; Red Nacional de Metástasis Cerebral, Madrid, Spain展开收起
PDF源文件 DOI 网页
322 天

Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis

作者
Fei Ji; Lei Zheng; Dapeng Chen; Peng Xia; Zhongyu Zou; Wei Liu; Jason Bugno; Emile Z. Naccasha; András Piffkó; Chuangyu Wen; Kangdi Li; Liping Xu; Sean Z. Luo; Xiaona Huang; Jiaai Wang; Chengwei Ju; Bei Liu; Yiyi Ji; Han Li; Steven J. Chmura; Sean P. Pitroda; Hua Laura Liang; Chuan He; Ralph R. Weichselbaum展开收起
作者单位
Department of Radiation and Cellular Oncology, USA; The Ludwig Center for Cancer Research, University of Chicago, Chicago, IL 60637, USA; Department of Chemistry, The University of Chicago, Chicago, IL 60637, USA; Howard Hughes Medical Institute, Chicago, IL 60637, USA; Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL, USA; Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA; Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, USA展开收起
PDF源文件 DOI 网页
211 天

Ensemble learning of pathology foundation models for precision oncology

作者
Xiangde Luo; Xiyue Wang; Feyisope Eweje; Xiaoming Zhang; Juan Luis Gomez Marti; Sarah Cascarino; Sen Yang; Yuchen Li; Ryan Quinton; Jinxi Xiang; Yuanfeng Ji; Zhe Li; Yijiang Chen; Colin Bergstrom; Ted Kim; Francesca Maria Olguin; Kelley Yuan; Matthew Abikenari; Andrew Heider; Sierra Willens; Sanjeeth Rajaram; Robert West; Joel Neal; Adam Schoenfeld; Maximilian Diehn; Chad Vanderbilt; Ruijiang Li展开收起
作者单位
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA; Stanford Institute for Human-Centered Artificial Intelligence, Stanford, CA, USA展开收起
PDF源文件 DOI 网页
385 天

Intratumoral Bacillus cereus orchestrates stem-like lymphoid niches to potentiate immunotherapy response in hepatocellular carcinoma

作者
Chupeng Hu; Wenhua You; Yedi Huang; Yuhan Zhang; Jingying Lu; Jianzhou Yuan; Ruimin Shan; Songmao Li; Ran Li; Qing Li; Minghao Li; Yongqiang Gao; Gao-Jun Teng; Yun Chen展开收起
作者单位
Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, Jiangsu, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, Jiangsu, China; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, Jiangsu, China; State Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; Center of Interventional Radiology & Vascular Surgery, Nurturing Center of Jiangsu Province for State Laboratory of Al Imaging & Interventional Radiology (Southeast University), Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China展开收起
PDF源文件 DOI 网页

FAQ

CANCER CELL审稿要多久?

截至2026-11-19,CrushSCI 收录了 CANCER CELL 的 16 篇完整审稿记录。最快一篇从收稿到录用用了 164 天(Chemotherapy enhances cancer vaccine efficacy and expands stem-like TCF1+CD8+ T cells,2026-03-31 收稿,2026-09-11 录用),最慢一篇用了 641 天;平均 315 天,中位数 279 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。